"Models, Econometric" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The application of mathematical formulas and statistical techniques to the testing and quantifying of economic theories and the solution of economic problems.
| Descriptor ID |
D017059
|
| MeSH Number(s) |
E05.318.740.500.600.500 E05.599.835.890.500 N05.715.360.750.530.500.500 N06.850.520.830.500.600.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Models, Econometric".
- Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
- Investigative Techniques [E05]
- Epidemiologic Methods [E05.318]
- Statistics as Topic [E05.318.740]
- Models, Statistical [E05.318.740.500]
- Models, Economic [E05.318.740.500.600]
- Models, Econometric [E05.318.740.500.600.500]
- Models, Theoretical [E05.599]
- Models, Statistical [E05.599.835]
- Models, Economic [E05.599.835.890]
- Models, Econometric [E05.599.835.890.500]
- Health Care [N]
- Health Care Quality, Access, and Evaluation [N05]
- Quality of Health Care [N05.715]
- Health Care Evaluation Mechanisms [N05.715.360]
- Statistics as Topic [N05.715.360.750]
- Models, Statistical [N05.715.360.750.530]
- Models, Economic [N05.715.360.750.530.500]
- Models, Econometric [N05.715.360.750.530.500.500]
- Environment and Public Health [N06]
- Public Health [N06.850]
- Epidemiologic Methods [N06.850.520]
- Statistics as Topic [N06.850.520.830]
- Models, Statistical [N06.850.520.830.500]
- Models, Economic [N06.850.520.830.500.600]
- Models, Econometric [N06.850.520.830.500.600.500]
Below are MeSH descriptors whose meaning is more specific than "Models, Econometric".
This graph shows the total number of publications written about "Models, Econometric" by people in this website by year, and whether "Models, Econometric" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 2002 | 1 | 1 | 2 |
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 2 | 2 |
| 2005 | 1 | 1 | 2 |
| 2007 | 1 | 0 | 1 |
| 2008 | 0 | 3 | 3 |
| 2011 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2018 | 0 | 2 | 2 |
| 2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Models, Econometric" by people in Profiles.
-
Svedbom A, Dal?n J, Iverg?rd M, Borse RH, Black CM, Luttropp K, Kachroo S. The value of persistence in treatment with subcutaneous TNF-alpha inhibitors for ankylosing spondylitis. Eur J Health Econ. 2020 Feb; 21(1):45-54.
-
Prioli KM, Karp JK, Lyons NM, Chrebtow V, Herman JH, Pizzi LT. Economic Implications of Pathogen Reduced and Bacterially Tested Platelet Components: A US Hospital Budget Impact Model. Appl Health Econ Health Policy. 2018 12; 16(6):889-899.
-
Lipton RB, Brennan A, Palmer S, Hatswell AJ, Porter JK, Sapra S, Villa G, Shah N, Tepper S, Dodick D. Estimating the clinical effectiveness and value-based price range of erenumab for the prevention of migraine in patients with prior treatment failures: a US societal perspective. J Med Econ. 2018 Jul; 21(7):666-675.
-
Nolte MT, Maroukis BL, Chung KC, Mahmoudi E. A Systematic Review of Economic Analysis of Surgical Mission Trips Using the World Health Organization Criteria. World J Surg. 2016 Aug; 40(8):1874-84.
-
Brown GC, Brown MM, Menezes A, Busbee BG, Lieske HB, Lieske PA. Cataract surgery cost utility revisited in 2012: a new economic paradigm. Ophthalmology. 2013 Dec; 120(12):2367-2376.
-
Dick A, Liu H, Zwanziger J, Perencevich E, Furuya EY, Larson E, Pogorzelska-Maziarz M, Stone PW. Long-term survival and healthcare utilization outcomes attributable to sepsis and pneumonia. BMC Health Serv Res. 2012 Nov 26; 12:432.
-
Bojke L, Epstein D, Craig D, Rodgers M, Woolacott N, Yang H, Sculpher M. Modelling the cost-effectiveness of biologic treatments for psoriatic arthritis. Rheumatology (Oxford). 2011 Sep; 50 Suppl 4:iv39-iv47.
-
Grant A, Wileman S, Ramsay C, Bojke L, Epstein D, Sculpher M, Macran S, Kilonzo M, Vale L, Francis J, Mowat A, Krukowski Z, Heading R, Thursz M, Russell I, Campbell M. The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease - a UK collaborative study. The REFLUX trial. Health Technol Assess. 2008 Sep; 12(31):1-181, iii-iv.
-
Gupta OP, Brown GC, Brown MM. A value-based medicine cost-utility analysis of idiopathic epiretinal membrane surgery. Am J Ophthalmol. 2008 May; 145(5):923-8.
-
Doan QV, Lange SM, Elfant A, Aguilar D, Reyes E, Lynn RB, Dubois RW. Disease-specific cost savings of treating nighttime versus daytime gastroesophageal reflux disease in an employed population. J Med Econ. 2008; 11(1):23-40.